# First Discussion of the First Engine

Discussion recorded: October 8, 2026
Project: Human Biological Sandbox
Status: discussion and proposed specification, not a validated whole-body prediction engine.

This document consolidates the engine discussion between the project owner and the assistant through this point. It preserves the owner's intentions, corrections, proposed requirements, research findings, and unresolved questions. It is a structured account, not a verbatim transcript. Statements of ambition are distinguished from demonstrated capabilities.

## 1. The owner's central idea

Treat the human body as a sandbox: represent its parts, cells, properties, measurements, and relationships, then calculate possible changes over time. The main engine should be general and extensible, intended to support different people and cases rather than one disease or one illustration.

The owner wants an engine capable of exploring many combinations of properties to investigate when a cell changes and how surrounding cells and body systems interact. The vision is larger than the current website animation or the present cardiac reference dataset.

Treatment, chemotherapy, and treatment recommendations are outside this project discussion. The owner mentioned treatment as contextual background, not as a requested engine feature.

## 2. Main engine and secondary search

The main engine simulates biological processes from starting conditions and explores possible future outcomes.

A secondary search option supplies a known outcome—such as an observed cell change or death—and searches combinations of conditions using the same biological simulation rules. Its purpose is to find scenarios consistent with that outcome.

The owner corrected the assistant's interpretation: this is not a questionnaire asking users to recount past events, and the project should not be reframed around reconstructing history as its primary purpose. The general simulation engine remains central. The known-outcome search is an additional use of that engine, not a replacement for it.

The assistant's proposed technical interpretation is forward simulation combined with parameter or initial-condition search. Matching an outcome can yield several possible explanations. A match alone does not establish which explanation actually occurred.

## 3. Information priorities

The agreed user-input order is:

1. Age.
2. Weight.
3. Height.
4. Additional details needed by the selected model.

This order should apply to both Manual and Auto modes. It is an interaction priority, not a claim that these three inputs determine all biological properties.

During conversation and exploration, the basics may be skipped. If a user provides later-stage details first, Auto should retain them and gently explain that the basics are useful first. It should redirect at most twice rather than repeatedly blocking the user.

A later clarification distinguishes exploration from calculation: age, weight, and height must be completed before the calculation starts. Selected dataset values also need confirmation. An unfinished job may still be saved as a draft.

Information received out of order should not be discarded. The interface should ask for the next missing basic input. Numerical values should include units when needed; the engine should not silently guess ambiguous units.

## 4. Reference datasets and indexed relationships

The owner wants credible external reference datasets, not invented default values. A reference entry should define the exact property, its units, applicable population or age range, required inputs, supported equation, uncertainty, and source.

The owner used heart size as an example: the relevant value for a young child differs from that for an adult. This requires defining the exact measurement and choosing a compatible model. “Heart size” by itself is too broad to be one universally applicable number.

Related factors should be indexed within the same dataset. These links identify dependencies and related properties, resembling a structured network of human-body information. An illustrative heart/stomach relationship was not accepted as an established biological equation or causal link.

Different property families may need different sources:

- Anatomy geometry and labels: BodyParts3D and other anatomy resources.
- Tissue and cell identity or location: HuBMAP and Human Cell Atlas.
- Molecular quantities: BioNumbers and model-specific measurements.
- Protein and gene-expression context: Human Protein Atlas and GTEx.
- Reaction and pathway relationships: Reactome.
- Physiological and mechanistic equations: Physiome and BioModels.
- Population body measurements: NHANES and, where applicable, WHO growth references.

These are candidate resources with different purposes. They do not together constitute an already imported, complete, certified database of all human properties. Geometry, expression atlases, population measurements, and reaction models cannot be substituted for one another without checking meaning, units, and applicability.

## 5. Independent copies for each job

Each new user job or session should receive an independent editable copy derived from the reference version. Changes within one job must not change the reference set or another user's job.

As basic information is entered, compatible models should calculate supported reference estimates. The user then reviews, confirms, or edits them. Unsupported properties remain unknown rather than receiving fabricated values.

Reference estimates and user-entered measurements must stay distinguishable. Accepting an estimate does not make it an observed measurement. If a baseline input changes, dependent estimates recalculate and their acceptance must be reviewed again; user-entered values should be preserved.

Jobs should be saved privately to the account, reopened, and exported. Each job should eventually record the engine and dataset release it used.

## 6. Server responsibilities and API

The owner requested moving database functions and calculations from the browser to the server to reduce browser work.

The agreed division is:

- Server: reference models, validation, session creation, calculations, applicability checks, account ownership checks, private persistence, and results returned through the API.
- Browser: collecting input, presenting results, editing and confirmation controls, loading and error states, and downloading the returned experiment data.

The server should recompute results rather than trusting numerical results supplied by the browser. Private jobs must only be accessible to their owner.

The project root for deployment remains dist. Server files stay within dist/backend and are excluded from public static output. This discussion does not authorize changing the existing homepage, atlas, theme, or deployment root.

## 7. Current implemented reference pilot

The local pilot contains 34 pediatric cardiac reference fields based on Table 2 of the Pediatric Heart Network study. It uses the Haycock body-surface-area equation:

BSA in square metres = 0.024265 × weight in kilograms^0.5378 × height in centimetres^0.3964.

For a compatible PHN measurement:

- Reference mean = published indexed mean × BSA^alpha.
- Descriptive band = (indexed mean ± 2 × indexed standard deviation) × BSA^alpha.
- Reference z-score = (entered measurement / BSA^alpha − indexed mean) / indexed standard deviation.

The descriptive band is not a confidence interval, a diagnosis, or an exact personal measurement. The three BSA-independent ratio fields use alpha zero.

The source concerns a healthy, non-obese pediatric reference population aged 18 years or younger and includes additional exclusions. Age determines applicability; after BSA adjustment, this source does not require an arbitrary universal age-growth multiplier. Adult cardiac estimates are not extrapolated from it.

This pilot supports cardiac reference measurements. It does not calculate DNA mutation, cell death, cancer, whole-body growth, or all organ and cell properties.

Local work also includes guided Auto intake, independent account jobs, server-side calculations, and a server readiness check for the basics before Continue. Tests and the local build passed during the discussion. These additions have not been published in this sequence of work.

## 8. Auto today and language models later

Auto currently uses server-side rules and reference search, not a connected general language model or OpenRouter.

The owner wants to consider a language model across the website later, helping with datasets, calculation priorities, measurements, and possible scenarios. This is deferred, not an implemented integration.

The assistant recommends separating suggestions from approved scientific rules. A future model could propose changes or assist with interaction, but proposed equations or parameters would need evidence and validation before becoming part of a new engine release. This is a recommendation for discussion, not an approved implementation detail.

## 9. Version 1 and immutable future releases

The owner identifies the engine's priorities and calculation rules as the heart of the project.

The requested first release is Version 1. The owner wants priorities, rules, formulas, reference datasets, and associated files held together in one versioned database, with an entry accessible from the menu.

Future changes to the rules, ideas, or behavior should create Version 2 or a later release instead of modifying Version 1. Existing jobs should remain tied to their original version so they remain reproducible.

This release registry, immutable database snapshot, version menu, and migration policy have not been implemented. The current pilot's technical dataset identifier is not the full requested Version 1 release system.

The distinction proposed for later design is an immutable engine release versus an editable user job copied from that release. Editing a job should not rewrite the released engine.

## 10. Cell change, cell death, and known outcomes

The owner wants a cell-change event represented in a machine-readable way, suggesting zero for unchanged and one for changed. The owner also discussed an already affected or dead cell as a known outcome supplied to the secondary search.

Earlier demo discussions established an illustrative dead, red central cell surrounded by normal cells, with a pathway visible in Known outcome + cases mode. That visual scenario is separate from the scientific engine under discussion.

A binary flag can record a precisely defined simulated event, such as whether a specified DNA alteration occurred. It cannot by itself encode the type of alteration, its functional effect, repair, cell survival, or cancer development.

The assistant clarified that DNA change alone is not a reliable rule for predicting cancer. A dead cell, a living altered cell, and a proliferating cancerous cell are different states. The owner's ambition is to investigate possible changes; it should not be documented as an already demonstrated individual cancer forecast.

Stages one through four were used conversationally by the owner to describe progression and possible outcomes. No universal biological staging system, fixed time to death, or validated stage-transition equation was agreed. Those labels need a specific definition before becoming computational rules.

## 11. Estimating cell populations

The owner proposed estimating numbers of cells from a person's measurements and gave two pounds of blood as an example. The suggested one-billion count was explicitly uncertain, not a chosen reference value.

A supported counting approach separates cell types:

Cell count = blood volume × concentration of the specified cell type.

If starting from blood mass, volume also requires a compatible density estimate or measurement. Counts of red cells, white cells, and other components must not be conflated. Whole-body counts require tissue composition and cell-type distributions, not a single mass-to-cell conversion factor.

Reference counts or population averages can support estimates with uncertainty. They do not reveal an individual's exact cellular state.

## 12. Large searches and the portable experiment

The owner anticipates very large numbers of property combinations and wants to preserve a first experiment that could be processed on larger computing infrastructure.

The requested portable artifact should ultimately include:

- Engine and reference-dataset release identifiers.
- Starting conditions, known outcome if supplied, units, and provenance.
- Biological rules, equations, parameter values, dependencies, and applicability.
- Unknown inputs, parameter ranges, and assumptions.
- Search instructions, stopping criteria, and computational settings.
- Reproducibility information such as solver version and random seeds when applicable.
- Results already obtained, uncertainty, and validation comparisons.

Some items in that list are assistant recommendations for making the requested single file executable and reproducible.

The owner mentioned sending the package to NVIDIA or OpenAI for additional processing. No outreach, upload, computing commitment, or acceptance by either organization has occurred or is authorized by this document.

A large search does not automatically require simulating every molecule or enumerating every possible combination. The assistant recommends evaluating sampling, parameter fitting, sensitivity analysis, and multiscale or reduced models. Actual computing requirements must be measured for a defined model; the discussion did not establish a runtime of billions of years.

## 13. What the research comparison found

### Biological calculations

Published apoptosis work models molecular reactions and their dynamics rather than inferring cell death from body measurements alone. Albeck and colleagues developed a model of extrinsic apoptosis and compared it with cell experiments under specified conditions. Those conditions and parameter assumptions matter when reusing the equations.

Spencer and colleagues showed that differences in protein states or levels can affect the timing and probability of death in human cell-line experiments even without the proposed explanation being a difference in DNA. This supports representing molecular state and variability.

Rey and colleagues' 2025 study measured interactions and killing by human natural killer cell populations. It supports treating attacking immune cells as distinct actors and tracking contacts and observations over time, rather than making all ordinary neighboring cells attackers.

### Related existing platforms

- Physiome develops linked models from molecular to organ-system scales.
- VCell supports mechanistic cell models, spatial and stochastic simulations, parameter estimation, and portable model formats.
- PhysiCell models interacting cells and their biochemical environment.
- BioModels provides literature-based mathematical models; its curation checks correspondence to source publications, which is not the same as validating a model for every person or use.
- Published identifiability research examines whether observed data can distinguish alternative parameter sets.
- A 2026 JCVI-associated study simulated the spatial and kinetic lifecycle of the genetically minimal bacterium JCVI-syn3A. This is substantial progress, but does not demonstrate a complete predictive human replica.

These findings support a modular, testable implementation. They do not establish a validated universal every-cell simulator from age, weight, and height.

## 14. Feasibility, novelty, and recommended wording

The assistant's assessment is that a versioned platform combining published models, editable job copies, forward simulations, known-outcome searches, and reproducible exports is technically plausible within clearly defined scopes.

The underlying ideas of multiscale simulation, mechanistic cell modeling, parameter search, and portable experiment archives already exist. The particular product workflow may be useful, but the research performed does not establish that it is unique. No exhaustive literature or patent novelty determination was performed.

Suggested project wording:

“Human Biological Sandbox: a versioned simulation platform for exploring possible biological changes, with an optional search for conditions consistent with a known outcome.”

The owner's general whole-body ambition should remain documented. The assistant recommends validating one reproducible process as the first scientific demonstration while retaining an architecture that can expand to other systems. This recommendation has not replaced the owner's general vision or been approved as the final model choice.

Increasing compute can expand a search. It cannot supply missing biological measurements, make an unsupported relationship correct, or guarantee that a matching simulated outcome identifies the actual cause.

## 15. Open decisions before implementation resumes

1. Define the first biological process, cell or tissue types, and intended observable outcome.
2. Choose the published model and document its experimental scope.
3. Define each property and dependency with units and evidence.
4. Decide how missing measurements and uncertainty are represented.
5. Define the secondary known-outcome search, comparison metric, and handling of multiple matches.
6. Define Version 1's immutable release schema and job linkage.
7. Choose a portable format and execution instructions.
8. Specify validation data and acceptance criteria.
9. Measure computing requirements for that defined experiment.
10. Review the specification with the owner before further engine implementation.

The latest instruction is to document and discuss the idea first. Biological-engine expansion and the full release registry remain paused. Creating this discussion file does not publish website changes.

## 16. Sources consulted and their roles

### Body and cardiac reference measurements

- Pediatric Heart Network, echo z-scores: https://www.pediatricheartnetwork.org/echo-z-scores/
- Lopez et al., 2017, original cardiac reference study and Table 2: https://www.pediatricheartnetwork.org/wp-content/uploads/2020/07/Lopez-Circulation.pdf
- Haycock et al., body surface area formula: https://pubmed.ncbi.nlm.nih.gov/650346/
- Blood-cell counting context: https://www.medlineplus.gov/ency/article/003644.htm
- Hatton et al., human cell count and size distribution: https://pubmed.ncbi.nlm.nih.gov/37722043/

### Cell mechanisms and experimental models

- Albeck et al., 2008, Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death: https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0060299
- Spencer et al., 2009, Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis: https://pubmed.ncbi.nlm.nih.gov/19363473/
- Rey et al., 2025, CD8α and CD70 mark human natural killer cell populations which differ in cytotoxicity: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1526379/full
- Nomenclature Committee on Cell Death, 2018 recommendations, background terminology: https://www.nature.com/articles/s41418-017-0012-4
- NCI, genetics of cancer, context for interpreting DNA alterations: https://www.cancer.gov/about-cancer/causes-prevention/genetics

### Simulation, model sharing, and searches

- Physiome Project: https://physiomeproject.org/
- Physiome Model Repository: https://physiomeproject.org/data-repositories/physiome-model-repository
- VCell: https://vcell.org/
- VCell capabilities and portable export formats: https://vcell.org/why-vcell-2
- PhysiCell: https://physicell.org/
- BioModels overview: https://www.ebi.ac.uk/training/online/courses/biomodels-quick-tour/what-is-biomodels/
- BioModels Parameters: https://www.ebi.ac.uk/training/online/courses/biomodels-quick-tour/what-is-biomodels-parameters/
- Robust parameter estimation and identifiability analysis with hybrid neural ordinary differential equations, 2024: https://www.nature.com/articles/s41540-024-00460-3
- Karr et al., 2012, whole-cell bacterial model: https://pubmed.ncbi.nlm.nih.gov/22817898/
- JCVI publication record, March 9, 2026, Bringing the genetically minimal cell to life on a computer in 4D: https://www.jcvi.org/publications/bringing-genetically-minimal-cell-life-computer-4d

The review used available official documentation, publication records, abstracts, and accessible article text. Some full-text pages were blocked or unavailable. This record does not claim that every available article, database, or source version was exhaustively read.

## 17. Owner's clarified case-trigger workflow

The owner further clarified that the project is a technology-based research simulation, with doctors reviewing generated cases. It is not a symptom checker or a treatment-selection system.

Requested workflow:

1. Assemble a case containing starting properties, measurements, model inputs, and the relevant dataset version.
2. Run many simulated combinations or trajectories.
3. Detect a precisely defined cell-change event, initially envisioned as a DNA-change event.
4. Mark the affected simulated cell red.
5. Preserve the triggering case, including the inputs and calculation trace, for review by a doctor.

The owner proposes retaining detailed case outputs when the event occurs rather than storing every full simulation. The assistant recommends also keeping compact run counts, failure counts, search settings, and reproducibility metadata, so the retained positive cases can be interpreted against the search that generated them. This is a proposed addition, not an implemented storage policy.

The doctor-review handoff is a desired project workflow. No clinician has been contacted, and no case or patient information has been sent. The current engine does not implement this biological search or establish that all human outcomes can be predicted.

Biological assumptions raised in the discussion must not become universal engine rules: a DNA-altered cell does not necessarily die; ordinary neighboring cells and the brain are not universal attackers of altered cells; and cancer stages describe disease extent rather than a cell's fixed progression toward death. Cancer diagnosis often involves examination of cells or tissue from a biopsy and may involve molecular testing; DNA difference alone is not the universal diagnostic criterion. These distinctions preserve the intended event-detection workflow without treating unverified descriptions of diagnosis, immune responses, or treatments as established equations.

Additional official references:

- NCI, cancer staging: https://www.cancer.gov/about-cancer/diagnosis-staging/staging
- NCI, cancer diagnosis and biopsy: https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis
- NCI, cancer-cell behavior and immune interactions: https://www.cancer.gov/about-cancer/understanding/what-is-cancer

This addition is a local discussion update. It does not change the published engine or authorize transmitting cases to a doctor.


## 18. Review of recent owner messages and previously under-emphasized requirements

This review covers the recent messages available in this conversation; it does not claim access to missing speech or unavailable earlier chats.

The earlier account summarized the trigger workflow but under-emphasized the following owner statements:

- Engineering contribution: the owner brings software, messaging-system, and language-model experience. The proposed contribution is computational exploration and an understandable case record for clinical review.
- Scope: symptoms and treatment selection are outside the requested engine. The owner wants to investigate cellular changes and their modeled conditions, not build a symptom questionnaire.
- Scale: the vision includes individual cells, populations potentially numbering millions, tissue locations, neighboring cells, and interactions. A red single-cell event is the initial reporting trigger, not a claim that disease consists of only one changed cell.
- Storage: detailed outputs should be retained when a specified change occurs. Retaining compact metadata about other runs is an assistant recommendation, not a replacement of this requested policy.
- Case handoff: a doctor should review the triggering case and its underlying inputs and calculations. Automated diagnosis, treatment, or external transmission has not been requested or implemented.
- Compute: the owner anticipates very large searches and wants a portable experiment that can later be processed on larger infrastructure. Required computing time has not yet been measured.
- Language model: continuous assistance with exploration is a future ambition; it must not silently rewrite a fixed engine release. Repeated adjustment to match one patient's known outcome remains development, not independent validation.
- Direction: the main simulator remains general and supports forward exploration; a known-outcome search is secondary. The owner's latest phrase about doing backward simulations does not clearly revoke his earlier explicit distinction.

The owner's statements about clinicians not knowing causes, diagnosis being DNA differences alone, universal attacks on altered cells, and inevitable death at stages two through four are recorded as his interpretation of the discussion, not adopted as universal biological facts or calculation rules. His concern is that a computational record might make possible mechanisms inspectable. The review should address that concern without introducing treatment features.

## 19. Public-document review and current feedback

Reviewed official public material from NCI, the PhysiCell project, EMBL-EBI BioModels, and VCell, plus the original PhysiCell publication. These are sources with different roles; none supplies a complete individual human-body prediction engine.

1. NCI explains that cancer involves uncontrolled growth and invasion, with changes in growth-control and repair genes. Immune cells can attack abnormal cells, but cancer cells can escape or modify that response. Implication: the model must distinguish DNA alteration, malignant behavior, immune recognition, survival, and death rather than treating them as one binary state.
2. PhysiCell provides a virtual laboratory for interacting cells and their biochemical environment, including growth, division, death, and immune interactions. Its project reports routine simplified simulations of 10,000 to one million cells on desktops. Implication: an interacting-cell prototype is feasible without first enumerating every cell in a human; that scale claim does not imply genome-level individual prediction.
3. BioModels distributes literature-based mechanistic models in standard formats. Curation checks correspondence to the original publication. Implication: reuse explicit equations and experimentally scoped parameters, while separately validating the intended application.
4. VCell supports biological models, numerical solvers, experimental-data-constrained parameter estimation, and SBML/SED-ML/COMBINE archive exports. Implication: forward simulation, known-outcome searches, and a portable experiment file have existing technical building blocks.

Current assistant feedback: the requested case-generation and clinician-review architecture is plausible within a defined biological scope. Universal accurate cancer prediction for any person from basic body measurements is not established by these documents. Version 1 should define a specific cell/tissue system and change event, reproduce a published experiment, retain immutable model rules and sources, and then test independent cases. The broader architecture can remain general. The red marker should identify the defined simulated event, with distinct fields for mutation, malignant behavior, immune interaction, and death when supported by the chosen model.

A proposed reproducible case record includes case identifier, tissue/cell identifiers, engine and dataset versions, input values and units, measured-versus-estimated provenance, model equations and parameter ranges, solver and random seed, event definition and time, relevant trajectory, uncertainty, and review status. This is a proposal, not a newly implemented engine or database schema.

Reviewed links:

- https://www.cancer.gov/about-cancer/understanding/what-is-cancer
- https://physicell.org/
- https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005991
- https://www.ebi.ac.uk/training/online/courses/biomodels-quick-tour/what-is-biomodels/
- https://vcell.org/why-vcell-2

The BMJ external-validation page could not be retrieved in this review; no claim of reading its full text is made. Documentation updated locally only. No website styling, engine implementation, or deployment settings changed.


## 20. First implemented cell-count calculation layer

The owner's request to research and make the calculation authorizes a local server implementation. Added dist/backend/cell-engine.mjs, a separately identified cell-count-1 module, and authenticated POST /api/community?route=cells/calculate. This is not the complete immutable biological-engine Version 1 registry.

Formula: count = volume in microliters × cell concentration per microliter. Tissue calculations require a supplied cell-type-specific volumetric density applicable to the chosen tissue. Blood calculations require a supplied concentration applicable to the specified blood volume. Mass alone is rejected: converting pounds of blood would first need a justified blood density to obtain volume, then a cell-type concentration. No generic mass-to-cell conversion is invented.

Supported volume units: uL, mL, L. Supported density units: cells/uL, cells/mL, cells/L, 10^9/L, 10^12/L. Each input requires a source and measured/reference/assumed provenance. Optional input bounds produce a conservative multiplication envelope, not a confidence interval. Missing, negative, nonfinite, inconsistent, unsupported-unit, or precision-overflow inputs are rejected. Results remain estimates and preserve their specified scope. Counts may be fractional expectations; the module does not claim to identify individual cells.

Platelets are excluded from this whole-cell counting interface because they are cell fragments. Red-cell counting does not supply a DNA model: mature human red blood cells have no nucleus. No default densities, organ proportions, DNA variants, cell-state transitions, or cancer probabilities are fabricated. The endpoint calculates on demand and does not automatically store inputs or send them externally.

Reviewed evidence: NHLBI documents CBC concentrations in cells per microliter and distinguishes platelets as fragments (https://www.nhlbi.nih.gov/health/blood-tests). Hatton et al.'s original research describes reference-model cell populations and multiple estimation methods, not a patient-specific universal weight formula (https://doi.org/10.1073/pnas.2303077120; accessible author paper https://ddd.uab.cat/pub/artpub/2023/a0ed8d20c578/hatton-et-al-2023-the-human-cell-count-and-size-distribution.pdf). BioModels offers reusable literature models and BioSimulations documents execution interfaces; neither has been integrated as a live remote computation service in this change. The CDC PDF was too large for the web reader and PMC access was blocked; their full contents were not represented as read.

Synthetic arithmetic test: 2 mL × 5 million cells/uL = 10 billion cells for the specified sample. This is a unit test, not an inferred patient measurement. Tests cover equivalent units, bound propagation, invalid inputs, precision limits, session access, CSRF, and rejection of client-supplied output numbers. All 13 current tests and the deployment build passed locally. The existing homepage, atlas, and dashboard interface are unchanged; no cell-count UI or full biological simulator is claimed. No deployment was performed for this update.


## 21. Published biological-model integration: first population model

Locally added a server model registry and numerical runner in dist/backend/biological-models.mjs. Authenticated GET biology/models lists the model; authenticated, CSRF-protected POST biology/simulate executes it and returns a reproducible experiment with parameters, units, provenance, equations, solver settings, and trajectory. No external service calls, automatic storage, or website design changes were introduced.

The first entry is kuznetsov-populations-1, implementing the untreated population equations reproduced in Section 2.1, equation (1), of https://doi.org/10.1007/s11538-013-9925-3. It models tumor population T and specific immune effector population E; it is not a model of cancer initiation, mutation, or every neighboring cell. Each initial population and parameter requires a value, matching unit, source, and measured/reference/assumed label. No published mouse parameters are silently substituted for patient parameters. Terms cover growth, carrying capacity, immune stimulation, inactivation, and elimination. Treatment extensions from the paper are excluded.

The runner uses RK4 step doubling, error control, nonnegative finite-population checks, bounded output size, and a work limit; difficult/stiff inputs fail rather than returning an unchecked trajectory. Numerical agreement tests cover analytic logistic growth, effector decay, and constant-effector target elimination. These verify equation implementation, not patient prediction. DNA-change and cancer-prediction results remain null. Population counts must refer to the model's specific effector and target cells; a generic whole-tissue count or red-blood-cell count must not automatically become its tumor population.

The broader integration request remains only partly achieved: mutation-specific pathways, individual-cell spatial behavior, measured parameter calibration, and live external solver adapters are not implemented. Choosing a DNA-change model requires a defined gene/variant, cell type, observable process, and compatible experimental data. Unknown mechanisms are not represented by fabricated equations. The 2022 follow-up https://doi.org/10.1007/s11538-022-01075-7 also discusses parameter fitting and non-unique fits; it does not validate this module for arbitrary people.

This separate computational model version does not silently replace any existing engine release. The complete immutable database registry, clinical review workflow, and full-body simulation remain future work. Implementation is local and not published.


## 22. Selected molecular-response model for the next gap

Selected Hunziker et al. (2010), p53–Mdm2 stress-response feedback, as a scoped next model, not a universally best cancer model: https://doi.org/10.1186/1752-0509-4-94. Checked equations (1)–(4) and Table 1 in the author-hosted paper https://www.nbi.dk/~mhjensen/papers/stressres.pdf. Implemented hunziker-p53-mdm2-1 through the existing private biology model and simulation APIs.

The state is free nuclear p53, Mdm2 mRNA, free Mdm2, and bound complex, in nM; time is hours. Publication resting parameters are available as explicitly labeled reference inputs, including kf derived from kb/kD. Starting concentrations are still required. It models signaling response to supplied conditions, not DNA mutation generation, exact genetic variants, cell death decisions, or cancer onset. No molecular-to-population coupling is invented.

Shared bounded numerical solver; tests cover analytic production/decay, binding conservation, correct units, missing inputs, and a short run with published reference parameters. Fast binding makes this model stiff: longer runs may exceed the solver work limit and require an appropriate stiff solver. Short-run success is not reproduction of every paper figure or clinical validation. The selected model fills a molecular-signaling capability, while spatial models, variant-specific effects, calibration, cross-model mappings, and a full release database remain unresolved. Local only; website appearance and deployment unchanged. No personal story is included.


## 23. Cell production page and scoped calculations

The new `cell-production.html` page contains three contiguous sections: blue for real cell production, pink for digital cell representations, and white for interpreting DNA changes. Local Three.js animations are schematic illustrations, not patient scans. DNA replication precedes mitosis, and cell production varies by tissue.

Authenticated server calculations provide ideal binary division (N = N0 × 2^d), sourced volume–concentration cell counts, and arithmetic totals of entered somatic-variant evidence criteria. Ideal division assumes complete rounds without cell loss; it does not supply a real growth rate.

Variant evidence uses the published ClinGen/CGC/VICC Somatic Oncogenicity SOP version 1 point system. It applies to small somatic variants in tumor cells, not a universal healthy/cancerous cell score. Entered evidence must include sources and independent evidence groups; duplicate criteria and selected overlapping combinations are rejected. These checks are partial and cannot verify the evidence scientifically. The calculator returns no diagnosis or final classification and requires expert review. Missing evidence remains unknown.

Sources: NHGRI Mitosis glossary, NIH Stem Cell Basics, NHLBI Blood Tests, Hatton et al. human cell count research, ClinGen Somatic Oncogenicity SOP, and NCBI ClinVar classification documentation. The original homepage and atlas files are unchanged; the new page is added to navigation.


## 24. Person-specific digital body initialization before simulation

### User requirement and corrected ordering

The first component is a body-initialization engine, not merely two informational pages. It takes the person’s available measurements at a test date and builds a virtual database of their body. The representation connects person → body parts → tissue compartments → cell populations or selected individual virtual cells → assigned properties. Body-part dimensions, tissue volumes, age, and other supported inputs inform initialization. Each object receives an identifier, units, provenance, and links to its related objects.

Only after that starting database exists does the scenario engine run. Each scenario receives a separate copy of the starting state and its own changed inputs or rules; it must not overwrite the person’s baseline or another case. Runs investigate how defined cell properties could change and preserve flagged cases for review. Virtual objects represent the model’s estimates and assumptions, not observed identities of every real cell.

### Proposed initialization calculations

1. Validate measurements and units and identify the organ, tissue, and relevant reference population.
2. Initialize measured geometry directly. Estimate missing geometry only with a published formula that applies to the person and required inputs.
3. Estimate each cell population as volume × cell concentration where both quantities are supported for that compartment. Alternatively, use an applicable cellular mass / mean-cell-mass model, explicitly excluding noncellular material and avoiding double counting. Neither method is a universal whole-body conversion.
4. Assign cell-type-specific property distributions, rather than one size to all cells. Store measured values separately from reference estimates, uncertainty ranges, and unknowns.
5. Check population totals, compartment bounds, units, and model applicability before creating scenario copies. Molecular concentrations and reaction rates require separate evidence; they cannot be inferred from cell counts alone.

### Age and differences between people

The user emphasizes age as an input to size and other properties. Age can affect organ growth, tissue composition, and cellular state, but cell size is not equal to age. Size also depends on cell type, tissue, cell-cycle state, and other biological conditions. No universal age-to-cell-size equation is adopted. Person-specific measurements determine supported differences; population references describe plausible ranges for missing inputs, not exact personal facts.

### Feedback and implementation boundary

The proposed architecture is: initialize a sourced digital baseline → make independent scenario copies → execute applicable biological models → save reviewable results. Begin with one measured tissue or compartment, verify its initialization, then expand. Represent large populations statistically and instantiate individual cells only where a spatial or lineage model needs them. This is a research approximation with explicit uncertainty. The whole-body initializer, object database, and scenario integration described here are requirements, not implemented features. Existing count and published-model modules are building blocks. No engine rules or website design were changed by documenting this clarification.

Research references:
- Hatton et al., The human cell count and size distribution: https://pmc.ncbi.nlm.nih.gov/articles/PMC10523466/ — reference cell populations and cell-type size ranges; not individual patient reconstruction.
- NIA, Does cellular senescence hold secrets for healthier aging?: https://www.nia.nih.gov/news/does-cellular-senescence-hold-secrets-healthier-aging — age-related cellular states vary by biological context.


## 25. Three-component algorithm and Version 1 five-year horizon

This is a proposed algorithm requirement, not an implemented or validated whole-body simulation.

### Component 1 — Person-specific starting database

Create the digital body at the test date from available person measurements and supported references. Assign identifiers and linked body parts, tissues, cell populations, and properties. Preserve units, sources, uncertainty, and unknowns. This baseline is the input to the following components.

### Component 2 — Property variations and priorities

Create independent scenario copies of the baseline. For each selected property, generate multiple plausible sizes or values within sourced ranges and model constraints. Link each property to its relevant age relationships and other input dependencies. Here, “property priorities” refers to the scenario-generation and calculation order, distinct from the age → weight → height intake order. Age does not universally determine cell size. Unsupported relationships remain unknown rather than being invented.

### Component 3 — Five-year evolution for Version 1

Version 1 has a five-year simulation horizon beginning at the baseline age. For each scenario, run the applicable rules over that interval, updating sizes and other properties where a published model supports time- or age-dependent change. Five years is the horizon, not five fixed sizes or five compulsory time steps; numerical step size depends on the selected model. Retain links to the unchanged baseline and the property-variation case. Record relevant state changes and flagged review cases with calculation traces. The proposed five-year scope does not establish five-year predictive accuracy.

Pipeline: starting digital body → independent property variations → five-year model evolution → reviewable case results. Later changes to these rules or the horizon belong to a new engine release rather than modifying Version 1. Sampling method, supported property list, time resolution, and validation criteria still need to be specified before implementation.


### Terminology clarification — “aging” means size variation in this project workflow

The user clarifies that “age/aging” in this proposed component refers to the changing sizes assigned to each selected property. Use “property-size evolution” in the interface to make that meaning explicit. Keep chronological person age as a separate input and the five-year horizon as a separate time parameter. This scoped terminology is not a biological definition of aging and does not introduce a universal age-to-size formula.


## Cell experiment implementation follow-up

**Correction and preservation:** keep the standalone laboratory calculations and tests as supporting research work. They were outside the requested Collect → Run properties → Age workflow and do not complete or replace Engine Version One. The repository knowledge record `docs/Cell Experiment Engine.md` preserves the modules, synthetic results, outstanding gaps and possible reuse. This addition is local and unpublished.

The local cell experiment laboratory adds a neutral colon-crypt model connecting division, hit-state inheritance, movement and shedding. Release cell-experiments/2 adds this model; release 1 keeps its original catalog. Sourced inputs and repeatable seeds are retained in portable results. Held-out comparison reports show errors without fitting. Biological validation and unsupported cross-model links remain open. Source: https://doi.org/10.1371/journal.pcbi.1003082


### Future possibilities demonstration
A separate section below Current/Past compares a stable reference cell, a transient change followed by repair, and a persistent change flagged for review. Visitors edit starting age, a one-to-five-year display horizon, reference/unknown baseline and scenario selection, then replay or pause. The animation does not assign probabilities or derive mutations from age. Unknown baseline is the default for a person with no known diagnosis. In Past, the target keeps its reference appearance until the first incoming signal arrives, then changes. These scripted visual examples remain separate from the server calculation engine.

Clarification: Future possibilities is an automatic repeating animation, matching Current/Past. It exposes no editable age, time-horizon, cell-state or scenario controls; only pause/play remains.

The second demo now matches the first hero heading and description styling: “View the present. Explore the future.” Its Current/Future buttons select either moving normal-looking reference cells or possible subsequent changes. Current is the default. No editable biological inputs are exposed in this illustrative section.

Future animation clarification: Current keeps normal reference cells. Future reveals an illustrated candidate source region and pathway; a signal moves along the entire route toward the target, which retains its baseline appearance until arrival and then turns red. The source-to-cell sequence is illustrative, not evidence of a patient’s mutation mechanism.
